Abstract
The brain depends on other organ systems of the body for oxygen, nutrients, and the elimination of metabolic byproducts. The primary route for such transfer of these essentials is the cerebrovasculature. The cerebrovasculature also participates in metabolizing or excluding xenobiotics, segregating components of the immune response, regulating pH and osmolarity of the cerebrospinal fluid, selectively distributing hormones, and impeding pathogenic invasion. Various aspects of these diverse functions are attributed to the complex structural and molecular properties of cerebral endothelial cells collectively referred to as the blood-brain barrier (1–7). The hallmark structural specialization of the blood-brain barrier is the tight junction between the endothelial cells, which prevents diffusion of plasma proteins and molecules of a similar size or larger (8–12). Other structural specializations include close apposition of astrocytic endfeet, sparsely distributed pericytes, and extensive association with microglia. Molecular specializations include endothelial expression of transporters and enzymes, such as those involved in xenobiotic metabolism (12–27).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rapoport, S. I. (1976) Blood-Brain Barrier in Physiology and Medicine. Raven, New York.
Neuwelt, E. A. (1989) Implication of the Blood-Brain Barrier and Its Manipulation. Plenum, New York.
Lathja, A. and Ford, D. H. (1968) Brain Barrier Systems. Elsevier, Amsterdam.
Bradbury, M. (1979) The Concept of a Blood-Brain Barrier. Wiley, New York.
Goldstein, G. W. and Betz, A. L. (1986) The blood-brain barrier. Sci. Am. 255, 74–83.
Janzer, R. C. (1993) The blood-brain barrier: cellular basis. J. Inherit. Metab. Dis. 16, 639–647.
Bradbury, M. W. (1993) The blood-brain barrier. Exp. Physiol. 78, 453–472.
Staddon, J. M. and Rubin, L. L. (1996) Cell adhesion, cell junctions and the blood-brain barrier. Curr. Opin. Neurobiol. 6, 622–627.
Hoffmann, W. and Schwarz, H. (1996) Ependymins: meningeal-derived extra-cellular matrix proteins at the blood-brain barrier. Int. Rev. Cytol. 165, 121–158.
Saunders, N. R. (1992) Development of the blood-brain barrier to macromolecules, in Barriers and Fluids of the Eye and Brain (Segal, M. B., ed.), CRC, Boca Raton, FL, pp. 128–158.
Betz, A. L. (1992) An overview of the multiple functions of the blood-brain barrier. NIDA Res. Monogr. 120, 54–72.
Peters, A., Palay, S. L., and Webster, H. (1991) The Fine Structure of the Nervous System, 3rd ed. Oxford University Press, Oxford.
Boado, R. J., Black, K. L., and Pardridge, W. M. (1994) Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Mol. Brain Res. 27, 51–57.
Fischer, S., Sharma, H. S., Karliczek, G. F., and Schaper, W. (1995) Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Mol. Brain Res. 28, 141–148.
Nag, S. (1995) Role of the endothelial cytoskeleton in blood-brain-barrier permeability to protein. Acta Neuropathol. (Bed.) 90, 454–460.
Pardridge, W. M., Golden, P. L., Kang, Y. S., and Bickel, U. (1997) Brain microvascular and astrocyte localization of P-glycoprotein. J. Neurochem. 68, 1278–1285.
Lechardeur, D., Phung-Ba, V., Wils, P., and Scherman, D. (1996) Detection of the multidrug resistance of P-glycoprotein in healthy tissues: the example of the blood-brain barrier. Ann. Biol. Clin. (Paris) 54, 31–36.
Jette, L., Murphy, G. F., Leclerc, J. M., and Beliveau, R. (1995) Interaction of drugs with P-glycoprotein in brain capillaries. Biochem. Pharmacol. 50,1701–1709.
Tatsuta, T., Naito, M., Mikami, K., and Tsuruo, T. (1994) Enhanced expression by the brain matrix of P-glycoprotein in brain capillary endothelial cells. Cell Growth Differ. 5, 1145–1152.
Jette, L., Pouliot, J. F., Murphy, G. F., and Beliveau, R. (1995) Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein. Biochem. J. 305, 761–766.
Lagrange, P., Livertoux, M. H., Grassiot, M. C, and Minn, A. (1994) Superoxide anion production during monoelectronic reduction of xenobiotics by preparations of rat brain cortex, microvessels, and choroid plexus. Free Radio. Biol. Med. 17, 355–359.
Minn, A., Ghersi-Egea, J., Perrin, R., Leininger, B., and Siest, G. (1991) Drug metabolizing enzyme in the brain and cerebral microvessels. Brain Res. Rev. 16, 65–82.
Bellamy, W. T. (1996) P-glycoproteins and multidrug reistance. Annu. Rev. Pharmacol. Toxicol. 36, 161–183.
Farrell, C. L. and Pardridge, W. M. (1991) Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc. Natl. Acad. Sci. USA 88, 5779–5783.
Boado, R. J. and Pardridge, W. M. (1990) The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier. Biochem. Biophys. Res. Commun. 166, 174–179.
James, J. H. and Fischer, J. E. (1981) Transport of neutral amino acids at the blood-brain barrier. Pharmacology 22, 1–7.
Betz, A. L. and Goldstein, G. W. (1980) The basis for active transport at the blood-brain barrier. Adv. Exp. Med. Biol. 131, 5–16.
Jacobs, J. M. (1982) Vascular permeability and neurotoxicity, in Nervous System Toxicology (Mitchell, C, ed.), Raven, New York, pp. 285–298.
Johnson, A. K. and Gross, P. M. (1993) Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 7, 678–686.
Koella, W. P. and Sutin, J. (1967) Extra-blood-brain barrier brain structures. Int. Rev. Neurobiol. 10, 31–55.
Zeman, W. and Innes, J. (1963) Craigie’s Neuroanatomy of the Rat. Academic, New York.
Lincoln, J. (1995) Innervation of cerebral arteries by nerves containing 5-hydrox-ytryptamine and noradrenaline. Pharmacol. Ther. 68, 473–501.
Jaffrey, S. R. and Snyder, S. H. (1995) Nitric oxide: a neural messenger. Ann. Rev. Cell Dev. Biol. 11, 417–440.
Haller, H. (1997) Endothelial function. General considerations. Drugs 53(Suppl. 1), 1–10.
Villringer, A. and Dirnagl, U. (1997) Optical Imaging of Brain Function and Metabolism 2. Physiological Basis and Comparison to Other Functional Neuroimaging Methods. Plenum, New York.
Moncada, S., Palmer, R. M., and Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109–142.
Pardridge, W. M., Yang, J., and Eisenberg, J. (1985) Blood-brain barrier protein phosphorylation and dephosphorylation. J. Neurochem. 45, 1141–1147.
Aschner, M. and Gannon, M. (1994) Manganese (Mn) transport across the rat blood-brain barrier: saturable and transferrin-dependent transport mechanisms. Brain Res. Bull. 33, 345–349.
Banks, W. A. and Kastin, A. J. (1989) Aluminum-induced neurotoxicity: alteration in membrane function at the blood-brain barrier. Neurosci. Biobehav. Rev. 13, 47–53.
Banks, W. A., Kastin, A. J., Maness, L. M., Banks, M. F., Shayo, M., and McLay, R. N. (1997) Interactions of beta-amyloids with the blood-brain barrier. Ann. NY Acad. Sci. 826, 190–199.
Larsen, F. S., Knudsen, G. ML, and Hansen, B. A. (1997) Pathophysiological changes in cerebral circulation, oxidative metabolism and blood-brain barrier in patients with acute liver failure. Tailored cerebral oxygen utilization. J. Hepatol. 27,231–238.
Selmaj, K. (1996) Pathophysiology of the blood-brain barrier. Springer Semin. Immunopathol. 18, 57–73.
Lo, W. D., Wolny, A. C, Timan, C, Shin, D., and Hinkle, G. H. (1993) Blood-brain barrier permeability and the brain extracellular space in acute cerebral inflammation. J. Neurol. Sci. 118, 188–193.
Bouldin, T. W., Mushak, P., O’Tuama, L. A., and Krigman, M. R. (1975) Blood-brain barrier dysfunction in acute lead encephalopathy: a reappraisal. Environ. Health Perspect. 12, 81–88.
Bradbury, M. W. and Deane, R. (1993) Permeability of the blood-brain barrier to lead. Neurotoxicology 14, 131–136.
Chang, L. W. and Hartmann, H. A. (1972) Blood-brain barrier dysfunction in experimental mercury intoxication. Acta Neuropathol. (Berl.) 21, 179–184.
Deane, R. and Bradbury, M. W. (1990) Transport of lead-203 at the blood-brain barrier during short cerebrovascular perfusion with saline in the rat. J. Neurochem. 54,905–914.
Eralinna, J. P., Soilu-Hanninen, M., Roytta, M., Hukkanen, V., Salmi, A. A., and Salonen, R. (1996) Blood-brain barrier breakdown and increased intercellular adhesion molecule (ICAM-1/CD54) expression after Semliki Forest (A7) virus infection facilitates the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 66, 103–114.
Goldstein, G. W. (1994) Blood-brain barrier in toxic encephalopathies. Neurobiol. Aging 15, 237,238.
Hertz, M. M., Bolwig, T. G., Grandjean, P., and Westergaard, E. (1981) Lead poisoning and the blood-brain barrier. Acta Neurol. Scand. 63, 286–296.
Kalaria, R. N. (1992) The blood-brain barrier and cerebral microcirculation in Alzheimer disease. Cerebrovasc. Brain Metab. Rev. 4, 226–260.
Kerper, L. E. and Hinkle, P. M. (1997) Lead uptake in brain capillary endothelial cells: activation by calcium store depletion. Toxicol. Appl. Pharmacol. 146,127–133.
Petrali, J. P., Maxwell, D. M., Lenz, D. E., and Mills, K. R. (1991) Effect of an anticholinesterase compound on the ultrastructure and function of the rat blood-brain barrier: a review and experiment. J. Submicrosc. Cytol. Pathol. 23, 331–338.
Struzynska, L., Walski, M., Gadamski, R., Dabrowska-Bouta, B., and Rafalowska, U. (1997) Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Mol. Chem. Neuropathol. 31, 207–224.
Vorbrodt, A. W., Dobrogowska, D. H., and Lossinsky, A. S. (1994) Ultracytochemical studies of the effects of aluminum on the blood-brain barrier of mice. J. Histochem. Cytochem. 42,203–212.
Zucker, D. K., Wooten, G. F., and Lothman, E. W. (1983) Blood-brain barrier changes with kainic acid-induced limbic seizures. Exp. Neurol. 79,422–433.
Ware, R. A., Chang, L. W., and Burkholder, P. M. (1974) An ultrastructural study on the blood-brain barrier dysfunction following mercury intoxication. Acta Neuropathol. (Bed) 30, 211–224.
Davis, E. J., Foster, T. D., and Thomas, W. E. (1994) Cellular forms and functions of brain microglia. Brain Res. Bull. 34, 73–78.
McCann, M. J., O’Callaghan, J. P., Martin, P. M., Bertram, T., and Streit, W. J. (1996) Differential activation of microglia and astrocytes following trimethyl tin-induced neurodegeneration. Neuroscience 72, 273–281.
Streit, W. J. (1996) The role of microglia in brain injury. Neurotoxicology 17, 671–678.
Fix, A. S., Ross, J. F., Stitzel, S. R., and Switzer, R. C. (1996) Integrated evalua-tion of central nervous system lesions: stains for neurons, astrocytes, and microglia reveal the spatial and temporal features of MK-801-induced neuronal necrosis in the rat cerebral cortex. Toxicol. Pathol. 24, 291–304.
Giordana, M. T., Attanasio, A., Cavalla, P., Migheli, A., Vigliani, M. C, and Schiffer, D. (1994) Reactive cell proliferation and microglia following injury to the rat brain. Neuropathol. Appl. Neurobiol. 20, 163–174.
Streit, W. J. (1990) An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J. Histochem. Cytochem. 38, 1683–1686.
Streit, W. J. and Kreutzberg, G. W. (1987) Lectin binding by resting and reactive microglia. J. Neurocytol. 16, 249–260.
Rosenstein, J. M., Krum, J. M., Sternberger, L. A., Pulley, M. T., and Sternberger, N. H. (1992) Immunocytochemical expression of the endothelial barrier antigen (EBA) during brain angiogenesis. Dev. Brain Res. 66, 47–54.
Sternberger, N. H. and Sternberger, L. A. (1987) Blood-brain barrier protein recognized by monoclonal antibody. Proc. Natl. Acad. Sci. USA 84, 8169–8173.
Mori, S., Sternberger, N. H., Herman, M. M., and Sternberger, L. A. (1992) Variability of laminin immunoreactivity in human autopsy brain. Histochemistry 97, 237–241.
Broadwell, R. D. and Sofroniew, M. V. (1993) Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp. Neurol. 120, 245–263.
Kleine, T. O., Hackler, R., and Zofel, P. (1993) Age-related alterations of the blood-brain-barrier (bbb) permeability to protein molecules of different size. Z. Gerontol. 26, 256–259.
Fukuda, K., Tanno, H., Okimura, Y., Nakamura, M., and Yamaura, A. (1995) The blood-brain barrier disruption to circulating proteins in the early period after fluid percussion brain injury in rats. J. Neurotrauma 12, 315–324.
Clinton, J., Royston, M. C, Gentleman, S. M., and Roberts, G. W. (1992) Amyloid plaque: morphology, evolution, and etiology. Mod. Pathol. 5,439–443.
de Figueiredo, R. J., Oten, R., Su, J., and Cotman, C. W. (1997) Amyloid deposition in cerebrovascular angiopathy. Ann. NY Acad. Sci. 826,463–471.
Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C, Carr, T., Clemens, J., Donaldson, T., and Gillespie, F. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523–527.
Martins, R. N., Robinson, P. J., Chleboun, J. O., Beyreuther, K., and Masters, C. L. (1991) The molecular pathology of amyloid deposition in Alzheimer’s disease. Mol. Neurobiol. 5, 389–398.
Uno, H., Alsum, P. B., Dong, S., Richardson, R., Zimbric, M. L., Thieme, C. S., and Houser, W. D. (1996) Cerebral amyloid angiopathy and plaques, and visceral amyloidosis in aged macaques. Neurobiol. Aging 17, 275–281.
Vinters, H. V., Pardridge, W. M., Secor, D. L., and Ishii, N. (1988) Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections. Am. J. Pathol. 133,150–162.
Vinters, H. V., Pardridge, W. M., and Yang, J. (1988) Immunohistochemical study of cerebral amyloid angiopathy: use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer’s disease amyloid precursor. Hum. Pathol. 19,214–222.
Vinters, H. V., Secor, D. L., Read, S. L., Frazee, J. G., Tomiyasu, U., Stanley, T. M., Ferreiro, J. A., and Akers, M. A. (1994) Microvasculature in brain biopsy specimens from patients with Alzheimer’s disease: an immunohistochemical and ultrastructural study. Ultrastruct. Pathol. 18, 333–348.
Walker, L. C, Price, D. L., Voytko, M. L., and Schenk, D. B. (1994) Labeling of cerebral amyloid in vivo with a monoclonal antibody. J. Neuropathol. Exp. Neurol. 53, 377–383.
Wisniewski, H. M., Vorbrodt, A. W., and Wegiel, J. (1997) Amyloid angiopathy and blood-brain barrier changes in Alzheimer’s disease. Ann. NY Acad. Sci. 826, 161–172.
Zlokovic, B. (1997) Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer’s disease pathology. Neurobiol. Dis. 4, 23–26.
Zlokovic, B. V. (1996) Cerebrovascular transport of Alzheimer’s amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. Life Sci. 59, 1483–1497.
Isaacson, R. L., Varner, J. A., and Jensen, K. F. (1997) Toxin-induced blood vessel inclusions caused by the chronic administration of aluminum and sodium fluoride and their implications for dementia. Ann. NYAcad. Sci. 825, 152–166.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Jensen, K.F., Olin, J.K., Varner, J.A., Isaacson, R.L. (1999). Immunohistological Markers of Cerebrovascular Integrity. In: Harry, J., Tilson, H.A. (eds) Neurodegeneration Methods and Protocols. Methods in Molecular Medicine™, vol 22. Humana Press. https://doi.org/10.1385/0-89603-612-X:271
Download citation
DOI: https://doi.org/10.1385/0-89603-612-X:271
Publisher Name: Humana Press
Print ISBN: 978-0-89603-612-3
Online ISBN: 978-1-59259-604-1
eBook Packages: Springer Protocols